E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2006 in the Prospect News Biotech Daily.

Corgentech changes name to Anesiva

By Elaine Rigoli

Tampa, Fla., June 21 - Corgentech, Inc. said Wednesday it has changed its name effective immediately to Anesiva, Inc. and will be listed on the Nasdaq as ANSV.

"Our new name reflects our focus on the development of improved pain-management therapies and on bringing them to market for patients and health care providers as soon as possible," chief executive officer John P. McLaughlin said in a news release.

Anesiva, located in South San Francisco, Calif., is a late-stage biopharmaceutical company that develops therapeutic treatments for pain.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.